KARA NOON: Open Payments
NPI 1326751025 · WEST LAWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 79 payments from 17 companies in 2025. Trend: 2023 $757 · 2024 $2,506 · 2025 $1,646
Food & beverage: $1,646
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $265 |
| Madrigal Pharmaceuticals | 8 | $203 |
| Janssen Biotech, Inc. | 11 | $172 |
| Ardelyx, Inc. | 5 | $169 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $165 |
| Daiichi Sankyo Inc. | 6 | $148 |
| Aimmune Therapeutics, Inc. | 3 | $91 |
| PFIZER INC. | 4 | $78 |
| QOL Medical, LLC | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
Products named: REZDIFFRA, RINVOQ, TREMFYA, IBSRELA, XIFAXAN, INJECTAFER, ZENPEP, DUPIXENT.
Industry payments across PA — which companies pay providers there.
